Does the Use of Dihydroartemisinin-Piperaquine in Treating Patients with Uncomplicated falciparum Malaria Reduce the Risk for Recurrent New falciparum Infection More than Artemether-Lumefantrine?

by Wisdom Akpaloo and Edward Purssell
Malaria Research and Treatment, Volume 2014 (2014), pp. 1-20

20 pp. 1.7 MB: 001_resize

The World Health Organization recommended the use of artemisinin-based combination therapies (ACTs) for treatment of uncomplicated falciparum malaria a decade ago in response to problems of drug resistance. This review compared two of the ACTs – Dihydroartemisinin-Piperaquine (DP) and Artemether-Lumefantrine (AL) to provide evidence which one has the ability to offer superior post-treatment prophylaxis at 28 and 42 days post-treatment.

(Visited 80 times, 1 visits today)
This entry was posted in Essential Medicines, General, Malaria. Bookmark the permalink.